Documents
Application Sponsors
Marketing Status
Application Products
001 | TABLET;ORAL | 2MG | 0 | LOPERAMIDE HYDROCHLORIDE | LOPERAMIDE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2000-01-06 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2002-10-04 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 3 | AP | 2002-10-04 | |
LABELING; Labeling | SUPPL | 4 | AP | 2002-10-04 | |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 5 | AP | 2002-10-04 | |
LABELING; Labeling | SUPPL | 6 | AP | 2002-10-04 | |
LABELING; Labeling | SUPPL | 20 | AP | 2007-10-23 | |
LABELING; Labeling | SUPPL | 44 | AP | 2020-06-08 | STANDARD |
LABELING; Labeling | SUPPL | 46 | AP | 2020-06-08 | STANDARD |
Submissions Property Types
SUPPL | 1 | Null | 0 |
SUPPL | 2 | Null | 0 |
SUPPL | 3 | Null | 0 |
SUPPL | 5 | Null | 0 |
SUPPL | 44 | Null | 15 |
SUPPL | 46 | Null | 15 |
CDER Filings
L PERRIGO CO
cder:Array
(
[0] => Array
(
[ApplNo] => 75232
[companyName] => L PERRIGO CO
[docInserts] => ["",""]
[products] => [{"drugName":"LOPERAMIDE HYDROCHLORIDE","activeIngredients":"LOPERAMIDE HYDROCHLORIDE","strength":"2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Over-the-counter","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"01\/06\/2000","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/anda\\\/2000\\\/75-232_Loperamide_prntlbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"LOPERAMIDE HYDROCHLORIDE","submission":"LOPERAMIDE HYDROCHLORIDE","actionType":"2MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Over-the-counter","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2000-01-06
)
)